Glycomine
Developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.
Launch date
Employees
Market cap
-
Enterprise valuation
$140—210m (Dealroom.co estimates Jun 2021.)
San Carlos California (HQ)
Authorizing premium user...